2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow bulevirtide: new trials by email Literature Review of bulevirtide trials Research Report on bulevirtide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide Brelovitug (BJT-778), Bulevirtide - Chronic Hepatitis D | Phase 2 / Phase 3 | Recruiting | Mirum Pharmaceuticals, Inc. | 120 | 2026-02-26 | 2026-10-27 |
| A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Tobevibart, Elebsiran, Bulevirtide - Viral Hepatitis | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 100 | 2025-08-05 | 2026-01-16 |
| Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD) Bulevirtide, Peginterferon Alfa-2a (PEG-IFN alfa) - Chronic Hepatitis Delta | Phase 2 | Completed | Gilead Sciences | 175 | 2019-05-31 | 2024-10-08 |
| Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent Myrcludex B, PEG IFN alfa-2a, Tenofovir - Chronic Viral Hepatitis B With Delta-agent | Phase 2 | Completed | Hepatera Ltd. | 90 | 2016-04-01 | 2021-04-30 |
Hepatitis D, Chronic (3) · Digestive System Diseases (1) · Hepatitis (1) · Hepatitis D (1) · Liver Diseases (1)
Gilead Sciences (1) · Hepatera Ltd. (1) · Mirum Pharmaceuticals, Inc. (1) · Vir Biotechnology, Inc. (1)
France (3) · Romania (3) · Germany (2) · Moldova (2) · Russia (2) · Spain (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Italy (1) · Netherlands (1) · Pakistan (1) · Ukraine (1)
PMID 39648559, PMID 38340811, PMID 38842520, PMID 39853842, PMID 41586499
2019 (1)